We make AI work for Science
Aganitha partners with global biopharma, personal & homecare, and material science companies to bring better medicines and products to market faster.
We go beyond first-gen AI — uncovering the why and how behind diseases, therapeutics, and formulations.From
Data to:
Aganitha Launches Igniva™
A Suite of AI Agents for Therapeutic Design and Research, built on 7+ years of global R&D collaborations.
Transforming biopharma R&D powered by deep science & deep tech
Aganitha is a new generation in silico company that integrates high-throughput sciences with deep learning-based generative models to solve complex drug discovery and development challenges.
Bringing a new drug to market takes $1-2B and 6-12 years. Advances in scRNA, multiomics, long read sequencing, structural biology, first principles based chemistry etc. now allows us to take far less time, at a lower cost and a higher probability of success.
Our services and solutions help drive this transformation with the following foundational elements.
Why Aganitha?
Leverage our experience and strengths to build transformational solutions in biopharma
Multi-domain skills
Deep Focus
Solutions foundation
Agile + Enterprise-grade
Client Centric
Client teams: Research + Informatics